Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin versus azithromycin pharmacokinetic and safety study in children with community-acquired pneumonia
2014-002867-13Phase 3
- Sponsor
- Sanofi
- Start
- Mar 2015
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in community-acquired pneumonia (CAP) comparing Telithromycin oral suspension with Azithromycin oral suspension (2 arms). Primary endpoint: Pharmacokinetic parameters.
02
Drugs
telithromycinazithromycin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2014-002867-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002867-13.